У нас вы можете посмотреть бесплатно Osteoporosis and Breast Cancer with Dr. Keith McCormick или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
In this informative webinar, Dr. Keith McCormick delves into the crucial connection between osteoporosis and breast cancer. Discover the essential insights and practical advice to manage bone health effectively while undergoing breast cancer treatment. Don't miss this chance to empower yourself with knowledge and support! Like👍 , Subscribe, and Share this video with anyone who cares about strong bones! Key Takeaways: 🦴 Baseline bone density and bone turnover markers (CTX, P1NP) are vital when diagnosed with breast cancer. ⚠️ Aromatase inhibitors can increase bone loss, but bisphosphonates like zoledronic acid can help mitigate this effect. 🏥 Bone health should be a primary concern during breast cancer treatment. ----------------------------------------------- Jump to the following topic: Case Study: 30:06 📝 Case Studies Reviewed: 📚 Detailed case studies illustrating changes in bone density with various breast cancer treatments Q+A Session: 51:24 ----------------------------------------------- Topics Covered: Breast Cancer Overview: 📈 1 in 8 women are diagnosed with breast cancer, with 66% presenting localized tumors initially. 🦴 Bone is often the primary site for metastatic disease. 🔄 An inverse relationship exists between osteoporosis and breast cancer risk. Breast Cancer Treatments: ➡️ Tamoxifen blocks estrogen receptors, leading to improved bone density. ➡️ Aromatase inhibitors reduce estrogen production but increase bone loss. ➡️ Bisphosphonates inhibit metastases and disrupt the tumor microenvironment. Bisphosphonate Therapy: ➡️ Recommended for postmenopausal women with breast cancer. ➡️ Typical dosing involves zoledronic acid given every 6 months for 3 years. ➡️ Helps reduce bone loss from aromatase inhibitors and metastases. ➡️ Risks include osteonecrosis of the jaw and atypical femur fractures. Marodyne LiV (Low Intensive Vibration) : Click the YouTube icon below. • Improving Bone Health: A Deep Dive into th... The Marodyne LiV is a vibration plate that uses small mechanical vibrations to stimulate the body's muscles and bones. The vibrations are designed to improve bone and muscle health and can be used as a supplement to an osteoporosis exercise program. ------------------------------------------------------------------------- . 💪Ready to take control of your bone health? Visit my website🌐, https://food4healthybones.com/, for even more resources and expert insights on building strong bones from the inside out! Visit Dr. McCormick's website: https://www.osteonaturals.com/ ----------------------------------------------------------------------- 💖Want personalized guidance on your bone health journey? Book a FREE consultation 📞 with me using this link: https://calendly.com/your-bones/disco... Remember, strong bones = a strong future! 💪💗 #bonehealth #osteoporosis #breastcancer #cancerandosteoporosis